Receive our newsletter – data, insights and analysis delivered to you
  1. Analysis
November 11, 2021

AI-related deals in the pharma industry decreased in H1 2021

AI-related deals made up 4% of all deals announced in the pharmaceutical sector.

By Saywah Mahmood

Artificial intelligence (AI) related deals made up 4% of all deals announced in the pharmaceutical sector in the first six months of 2021.

This represents a decrease from the figure of 4.4% in the last six months of 2020 and a decrease from 4.7% in the first six months of 2020.

GlobalData’s deals database looks at mergers, acquisitions and venture capital and private equity investments taking place daily between thousands of companies across the world.

Free White Paper

AI-related deals in the pharma industry decreased in H1 2021

By
Enter your details to receive the free paper:

In the first six months of 2021, the overall number of announced deals in the pharmaceutical sector increased by 8.6%, from the same period in 2020.

GlobalData's thematic approach to sector activity seeks to group key company information on investments to see which industries are best placed to deal with any issues they may encounter.

Content from our partners
How Hengst helped to keep Germany’s charity “star singers” shining
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
Patient-centric pharma logistics: How CRYOPDP delivers hope worldwide

These themes, of which AI is one, are best thought of as "any issue that keeps a CEO awake at night", and by tracking them, it becomes possible to ascertain which companies are leading the way on specific issues and which ones have some work to do.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU